Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
17.98
+0.22 (1.24%)
At close: Dec 5, 2025
SHA:600521 Revenue
Zhejiang Huahai Pharmaceutical had revenue of 1.89B CNY in the quarter ending September 30, 2025, a decrease of -10.70%. This brings the company's revenue in the last twelve months to 8.71B, down -6.85% year-over-year. In the year 2024, Zhejiang Huahai Pharmaceutical had annual revenue of 9.55B with 14.91% growth.
Revenue (ttm)
8.71B
Revenue Growth
-6.85%
P/S Ratio
3.08
Revenue / Employee
960.69K
Employees
9,065
Market Cap
26.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.55B | 1.24B | 14.91% |
| Dec 31, 2023 | 8.31B | 42.97M | 0.52% |
| Dec 31, 2022 | 8.27B | 1.62B | 24.42% |
| Dec 31, 2021 | 6.64B | 158.36M | 2.44% |
| Dec 31, 2020 | 6.49B | 1.10B | 20.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |